Remed Co.,Ltd. (KOSDAQ:302550)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,245.00
-30.00 (-1.32%)
At close: Oct 23, 2026

Remed Revenue

Remed had revenue of 7.37B KRW in the quarter ending June 30, 2026, with 32.68% growth. This brings the company's total for the last twelve months to 27.05B, up 10.52% year-over-year. In the year 2025, Remed had annual revenue of 24.50B, down -4.11%. That makes Remed the 33,693rd largest company in the world by revenue and 2,151st in South Korea.

Revenue (ttm)
27.05B
Revenue Growth
+10.52%
P/S Ratio
2.47
Revenue / Employee
307.41M
Employees
88
Market Cap
66.80B

Revenue Chart

Revenue by Geography

  • Europe 9.39B 38.3%
  • South Korea 6.88B 28.1%
  • Other 6.80B 27.8%
  • Japan 1.34B 5.5%
  • China 97.37M 0.4%
Fiscal year ended Dec 31, 2025 See the full Remed breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202524.50B-1.05B-4.11%
Dec 31, 202425.55B7.02B37.86%
Dec 31, 202318.54B-2.83B-13.23%
Dec 31, 202221.36B1.17B5.79%
Dec 31, 202120.20B3.56B21.42%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
DRGEM109.45B
Genoray107.88B
JPI Healthcare46.86B
L&K Biomed39.94B
Hironic37.10B
SELVAS Healthcare31.69B
Dynamic solution15.11B
QuantaMatrix3.15B
Revenue Rankings